This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Christian Sorensen: Innovator in Injection Device Technology
Introduction
Christian Sorensen is a notable inventor based in Hillerod, Denmark. He has made significant contributions to the field of medical devices, particularly in the design of injection devices. His innovative approach has led to the development of a unique patent that addresses critical issues in medication delivery.
Latest Patents
Christian Sorensen holds a patent for an "Injection device with a dose setting limiter." This invention features an end-of-content arrangement that prevents the dose setting member of an injection device from being set to a dose larger than the medicament remaining in the device. The design is particularly suitable for injection devices that operate with non-equidistant dose volumes. The arrangement includes an indentation on the housing or on the dose setting and injection member, which arrests a stop member when less than one dose unit is left in the cartridge. This innovative mechanism ensures that a dose larger than the remaining medication cannot be set, enhancing safety and efficacy in medication administration.
Career Highlights
Christian Sorensen is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to focus on developing advanced medical technologies that improve patient outcomes.
Collaborations
Throughout his career, Christian has collaborated with talented professionals, including Claus Schmidt Moller and Steffen Hansen. These collaborations have fostered a creative environment that encourages innovation and the development of cutting-edge medical solutions.
Conclusion
Christian Sorensen's contributions to injection device technology exemplify the importance of innovation in healthcare. His patent for an injection device with a dose setting limiter showcases his commitment to improving patient safety and medication delivery. Through his work at Novo Nordisk and collaborations with fellow professionals, he continues to make a significant impact in the field of medical devices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile